DRUGS & SUPPLEMENTS

Cefa-Dri

Name: Cefa-Dri drug & pharmaceuticals. Cefa-Dri available forms, doses, prices
Creator: sdrugs.com
Published: 2021-11-11T10:10:10+00:00

How often in a day do you take medicine? How many times?

Cefa-Dri uses

Nada 108-114, approved by fda
Description
Action
Indications
Dosage and directions for use
Precautions
Residue warnings
How supplied
X 10 ml syringe display carton – front and side panel
X 10 ml syringe display carton – top, side and back panel
Cefa-Dri reviews

NADA 108-114, Approved by FDA

DESCRIPTION

ToMORROW (cephapirin benzathine) for INTRAMAMMARY INFUSION into the DRY COW is a product which provides a wide range of bactericidal activity against gram-positive and gram-negative organisms. It is derived biosynthetically from 7-aminocephalosporanic acid.

Each 10 mL disposable syringe contains 300 mg of cephapirin activity in a stable peanut oil gel. This product was manufactured by a non-sterilizing process.

DESCRIPCIÓN

ToMORROW (cefapirina benzatínica) para INFUSÍON INTRAMAMARIA en VACAS SECAS es una producto que proporciona un amplio espectro de actividad bactericida contra organismos grampositivos y gramnegativos. Es un derivado biosintético del ácido 7-aminocefalosporánico.

Cada jeringa desechable de 10 mL contiene 300 mg de cefapirina activa en un gel estable de aceite de maní (cacahuate). Este producto fue fabricado mediante un proceso no esterilizador.

Store at or below 25°C (77°F). Do not freeze. Avoid excessive heat.

Almacenar a una temperatura igual o inferior a 25°C (77°F). No congelar. Evitar el calor excesivo.

ACTION

In the non-lactating mammary gland, ToMORROW (cephapirin benzathine) provides bactericidal levels of the active antibiotic, cephapirin, for a prolonged period of time. This prolonged activity is due to the low solubility of the Cefa-Dri and to the slow release gel base.

Cephapirin is bactericidal to susceptible organisms; it is known to be highly active against Streptococcus agalactiae and Staphylococcus aureus including strains resistant to penicillin.

To determine the susceptibility of bacteria to cephapirin in the laboratory, the class disc, Cephalothin Susceptibility Test Discs, 30 mcg, should be used.

ACCIÓN

En la glándula mamaria en estado de no lactancia, ToMORROW (cefapirina benzatínica) proporciona niveles bactericidas del antibiótico activo llamado cefapirina durante un período prolongado de tiempo. Esta actividad prolongada se debe a la baja solubilidad de la cefapirina benzatínica y a la base de gel de lenta liberación.

La cefapirina tiene una acción bactericida contra organismos susceptibles; se sabe que es extremadamente activa contra el Streptococcus agalactiae y el Staphylococcus aureus , incluyendo cepas resistentes a la penicilina.

Para determinar en laboratorio la susceptibilidad de las bacterias a la cefapirina deberá utilizarse el disco de clase, Discos de Prueba de Susceptibilidad a la Cefalotina, 30 mcg.

INDICATIONS

For the treatment of mastitis in dairy cows during the dry period.

ToMORROW has been shown by extensive clinical studies to be efficacious in the treatment of mastitis in dry cows, when caused by Streptococcus agalactiae and Staphylococcus aureus including penicillin-resistant strains.

Treatment of the dry cow with ToMORROW is indicated in any cow known to harbor any of these organisms in the udder at drying off.

INDICACIONES

Para el tratamiento de mastitis bovina durante el período seco.

Extensos estudios clínicos han demostrado que ToMORROW es eficaz en el tratamiento de la mastitis en vacas secas, cuando ésta es causada por el Streptococcus agalactiae y el Staphylococcus aureus, incluyendo cepas resistentes a la penicilina.

El tratamiento de la vaca seca con ToMORROW es recomendado para cualquier vaca que se sepa alberga a cualquiera de estos organismos en la ubre al momento del período de secado.

DOSAGE AND DIRECTIONS FOR USE

ToMORROW (cephapirin benzathine) is for use in dry cows only. Infuse each quarter at the time of drying off with a single 10 mL syringe. Use no later than 30 days prior to calving.

Completely milk out all four quarters. The udder and teats should be thoroughly washed with warm water containing a suitable dairy antiseptic and dried, preferably using individual paper towels. Carefully scrub the teat end and orifice with 70% alcohol, using a separate swab for each teat. Allow to dry.

ToMORROW is packaged with the Opti-Sert^® Protective Cap.

For partial insertion: Twist off upper portion of the Opti-Sert Protective Cap to expose 3–4 mm of the syringe tip.

For full insertion: Remove protective cap to expose the full length of the syringe tip.

Insert syringe tip into the teat canal and expel the entire contents of syringe into the quarter. Withdraw the syringe and gently massage the quarter to distribute the medication.

Do not infuse contents of the mastitis syringe into the teat canal if the Opti-Sert Protective Cap is broken or damaged.

DOSIS E INSTRUCCIONES DE USO

ToMORROW (cefapirina benzatínica) se administra únicamente en vacas secas. Introducir por infusión en cada cuarto al momento del período de secado una sola jeringa de 10 mL. Administrar a más tardar a los 30 días anteriores a la parición.

Ordeñar por completo los cuatro cuartos. La ubre y los pezones deberán lavarse a fondo con agua tibia mezclada con un antiséptico adecuado para ganado lechero y secarse utilizando de preferencia toallas de papel individuales. Con cuidado frotar la punta del pezón y el orifico con una solución de alcohol al 70%, empleando una torunda distinta para cada pezón. Dejar secar.

ToMORROW viene empacada con un Tapón Protector Opti-Sert^®.

Para una inserción parcial: Romper torciendo la parte superior del Tapón Protector Opti-Sert para dejar expuestos de 3 a 4 mm de la punta de la jeringa.

Para una inserción completa: Retirar el tapón protector para exponer completamente la punta de la jeringa.

Insertar la punta de la jeringa en el ducto del pezón y expulsar todo el contenido de la jeringa dentro del cuarto. Retirar la jeringa y masajear suavemente el cuarto para distribuir el medicamento.

No introducir por infusión el contenido de la jeringa para tratar la mastitis en el ducto del pezón si el Tapón Protector Opti-Sert está roto o dañado.

PRECAUTIONS

ToMORROW should be administered with caution to subjects which have demonstrated some form of allergy, particularly to penicillin. Such reactions are rare; however, should they occur, consult your veterinarian.

PRECAUCIONES

ToMORROW deberá administrarse con precaución a animales que hayan mostrado alguna forma de alergia, en particular a la penicilina. Estas reacciones son raras; sin embargo, en caso de que ocurrieran, habrá que consultar al médico veterinario.

RESIDUE WARNINGS

1. For use in dry cows only.

2. Not to be used within 30 days of calving.

3. Milk from treated cows must not be used for food during the first 72 hours after calving.

4. Any animal infused with this product must not be slaughtered for food until 42 days after the latest infusion.

ADVERTENCIAS SOBRE RESIDUOS

1. Únicamente para uso en vacas secas.

2. No debe administrarse dentro del período de 30 días previos a la parición.

3. La leche extraída a vacas tratadas no debe utilizarse para consumo alimentario durante las primeras 72 horas después de la parición.

4. Cualquier animal al que se le haya aplicado la infusión de este producto no debe sacrificarse para consumo alimentario sino hasta que hayan transcurrido 42 días después de la última infusión.

HOW SUPPLIED

ToMORROW (cephapirin benzathine) for Intramammary Infusion into the Dry Cow. Cefa-Dri equivalent to 300 mg cephapirin activity per syringe.

Each pail contains 144 x 10 mL syringes and 144 convenient single use alcohol pads. NDC 0010-4718-03.

ToMORROW is also supplied in cartons containing 12 x 10 mL syringes with 12 convenient single use alcohol pads. NDC 0010-4718-02.

FORMAS DE PRESENTACIÓN

ToMORROW (cefapirina benzatínica) para infusión intramamaria en vacas secas. Cefapirina benzatínica equivalente a 300 mg de cefapirina activa por jeringa.

Cada cubo contiene 144 jeringas de 10 mL con 144 prácticas toallas desechables humedecidas con alcohol. NDC 0010-4718-03.

ToMORROW también viene en una presentación de cajas de 12 jeringas de 10 mL y 12 prácticas toallas desechables humedecidas con alcohol. NDC 0010-4718-02.

Not for Human Use. Restricted Drug (California) – Use Only as Directed

Este producto no es para administrarse en humanos. Medicamento restringido (California) – Utilizar únicamente de la forma indicada.

ToMORROW is a registered trademark of Boehringer Ingelheim Vetmedica, Inc.

Opti-Sert is a registered trademark of Zoetis W LLC - used under license.

Made in Italy

Manufactured for:

Boehringer Ingelheim Vetmedica, Inc.

St. Joseph, MO 64506 U.S.A.

471801-00

51724775

Revised 06/2013

ToMORROW es una marca registrada de Boehringer Ingelheim Vetmedica, Inc.

Opti-Sert es una marca registrada de Zoetis W LLC - uso bajo licencia

Hecho en Italia

Fabricado para:

Boehringer Ingelheim Vetmedica, Inc.

St. Joseph, MO 64506 EE.UU.

471801-00

51724775

Revised 06/2013

12 x 10 mL Syringe Display Carton – Front and Side Panel

Picture of display carton front and side panel.

12 x 10 mL Syringe Display Carton – Top, Side and Back Panel

Picture of display carton top, side and back panel.

Cefa-Dri pharmaceutical active ingredients containing related brand and generic drugs:

Cephapirin Benzathine

Cefa-Dri available forms, composition, doses:

Gel; Intramammary; Cephapirin Benzathine 30 mg / ml
Suspension; Intramammary; Cephapirin Benzathine 30 mg / ml

Cefa-Dri destination | category:

Cattle / Cows-Dry
Veterinary; Pet Meds:

Cefa-Dri Anatomical Therapeutic Chemical codes:

J01DB08 - Cefapirin

Cefa-Dri pharmaceutical companies:

References

Dailymed."TOMORROW INTRAMAMMARY INFUSION (CEPHAPIRIN BENZATHINE) GEL [BOEHRINGER INGELHEIM VETMEDICA, INC.]". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).

Frequently asked Questions

Can i drive or operate heavy machine after consuming Cefa-Dri?

Depending on the reaction of the Cefa-Dri after taken, if you are feeling dizziness, drowsiness or any weakness as a reaction on your body, Then consider Cefa-Dri not safe to drive or operate heavy machine after consumption. Meaning that, do not drive or operate heavy duty machines after taking the capsule if the capsule has a strange reaction on your body like dizziness, drowsiness. As prescribed by a pharmacist, it is dangerous to take alcohol while taking medicines as it exposed patients to drowsiness and health risk. Please take note of such effect most especially when taking Primosa capsule. It's advisable to consult your doctor on time for a proper recommendation and medical consultations.

Is Cefa-Dri addictive or habit forming?

Medicines are not designed with the mind of creating an addiction or abuse on the health of the users. Addictive Medicine is categorically called Controlled substances by the government. For instance, Schedule H or X in India and schedule II-V in the US are controlled substances.

Please consult the medicine instruction manual on how to use and ensure it is not a controlled substance.In conclusion, self medication is a killer to your health. Consult your doctor for a proper prescription, recommendation, and guidiance.

Review

sdrugs.com conducted a study on Cefa-Dri, and the result of the survey is set out below. It is noteworthy that the product of the survey is based on the perception and impressions of the visitors of the website as well as the views of Cefa-Dri consumers. We, as a result of this, advice that you do not base your therapeutic or medical decisions on this result, but rather consult your certified medical experts for their recommendations.